Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 spike conformation determines plasma neutralizing activity
John E. Bowen, Alexandra C. Walls, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25

Showing 25 citing articles:

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 509
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 199
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 872-880.e3
Open Access | Times Cited: 198
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 175
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 735-742
Open Access | Times Cited: 146
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 66
Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
Dibya Ghimire, Yang Han, Maolin Lu
Viruses (2022) Vol. 14, Iss. 6, pp. 1255-1255
Open Access | Times Cited: 45
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 44
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Timothy J.C. Tan, Zongjun Mou, Ruipeng Lei, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 38
Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2022-01-28
Antonia Netzl, Sina Türeli, Eric B. LeGresley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
Amin Addetia, Young‐Jun Park, Tyler N. Starr, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112621-112621
Open Access | Times Cited: 19
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Allison J. Greaney, Rachel Eguia, Tyler N. Starr, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010592-e1010592
Open Access | Times Cited: 25
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Janice Zhirong Jia, Chee Wah Tan, Samuel M. S. Cheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Allison J. Greaney, Rachel Eguia, Tyler N. Starr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Timothy J.C. Tan, Zongjun Mou, Ruipeng Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
Chengcheng Fan, Alexander A. Cohen, Miso Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
Roberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Rapid screening methods for universal binding peptide aptamers against SARS-CoV-2 variant spikes, including omicron variants, and their application to diagnostic and therapeutic agents.
Nakanobu Hayashi
Research Square (Research Square) (2023)
Closed Access
Rapid screening methods for universal binding peptide aptamers against SARS-CoV-2 variant spikes, including omicron variants, and their application to diagnostic and therapeutic agents.
Nakanobu Hayashi, Chikako Abe, Jiro Kikuchi, et al.
Research Square (Research Square) (2023)
Closed Access
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine
Yuanyuan Wang, Yunqi Hu, Yong Ma, et al.
Vaccine (2023) Vol. 41, Iss. 52, pp. 7641-7646
Closed Access
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Janice Zhirong Jia, Chee Wah Tan, Samuel M. S. Cheng, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top